Suppression of the TSH response to TRH by thyroxine therapy in differentiated thyroid carcinoma patients.

Abstract

Absent response of serum thyrotrophin (TSH) after stimulation with 200 micrograms synthetic thyrotrophin-releasing hormone (TRH) was used as a criterion of adequate suppression of TSH in the treatment of thyroid carcinoma patients with thyroxine. The mean causing total suppression of the response was 223 micrograms of thyroxine per day. At this dose level… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.